UK's Leading Patient Referral Software to Get Even Better

ArdentiaArdentia, a leading provider of business intelligence solutions, has announced new advances in its cutting-edge software, which enables trusts to protect and increase their market share. Activity Flow Analytics (AFA) is about to become even faster to use, with enhanced graphics and further-improved on-screen presentation of data. Developed last year, AFA is the most affordable and advanced option for tracking patient referrals and for benchmarking mortality and readmission rates against local competitors, and across England and Wales as a whole.

Among the customers to benefit from the upgrade, which happens this spring, is West Suffolk Hospital NHS Trust which was among the first users of the system. AFA has already brought major benefits, and the information it generates is being used to support its application for foundation trust status.

Carl Kwiatkowski, West Suffolk's business and marketing manager, said: "With the changes occurring within the NHS around GP commissioning, we had to be looking at market share, not only in our core areas but the peripheral areas of the Suffolk community. Where we have invested time and worked with GPs, Ardentia has been able to identify an increase in market share. If other organisations were looking for a product that was value for money and provided ease of use, I would strongly recommend Ardentia Activity Flow Analytics."

The system was developed last year but is undergoing further improvement through the introduction of Ardentia's Cassius Vision technology. This will make the system even quicker to use, while sharper graphics will mean even better and bolder presentation of on-screen information.

Former PCT chief executive Ian Rogerson (1), now an independent consultant, commented: "The acute sector is undergoing massive change, with trusts having to move towards foundation status and the emergence of GP commissioning consortia. It is essential for business managers to be able to track which referrals are coming to them and which aren't."

"Those that do will be able to identify areas of strength and weakness and adapt their performance, protecting and even increasing their market share and the vital income that it brings. I have seen the benefits that AFA is bringing to Ardentia customers and believe that it's a highly effective solution, which meets their needs in a rapidly changing healthcare environment" he continued.

Benefits of AFA to healthcare providers include the ability to:

  • Monitor patient flow between all healthcare organisations submitting data to the Secondary Uses Service (SUS), in England
  • Understand market share for all services provided and track changes over time
  • Identify key competitors and use in-depth analysis to identify information that would help improve market share
  • Perform comparative analysis between healthcare providers across a wide range of measures by specialty and HRG.
  • Benchmark nationally for mortality
  • Benchmark nationally for readmissions within 30 days
  • Identify areas where productivity can be improved
  • Use the GIS tool to identify geographical activity patterns.

Gary Luke, Ardentia MD, concluded: "AFA was developed because there was a clear need for healthcare providers to be able to benchmark their performance and identify why they are winning or losing referrals. This is already important but will become even more so with GP consortia. Trusts need to know whether they are losing business because of a weakness in their performance, or possibly because they haven't marketed themselves effectively enough, so consortia are unaware of the excellence of their services. We believe that our system is the best and most affordable around, but we also believe in talking to our customers to find ways in which it can be further improved. The forthcoming upgrades are proof of our commitment to making sure that our systems stay ahead of the competition, allowing our customers to do the same."

About Ardentia
Since 1990, Ardentia has been providing world-class business intelligence solutions to healthcare organisations to support them in the delivery of high quality, clinically effective care to patients and health service users.

Ardentia specialises in helping healthcare organisations, using its business intelligence platform, to identify areas of clinical and financial under-performance, enabling them to reinvest resources to deliver a better, more cost effective service.

Ardentia is also responsible for the user interface of the Secondary Uses Service in England, to which all healthcare providers must submit data. This means that thousands of NHS employees make use of Ardentia's software each year, in addition to staff in the 80 plus NHS trusts that make-up its client base.

In use at all levels of the NHS, Ardentia's specialist capability delivers information to the right people at the right time, enabling decision making supported by the best available data - called 'Evidence Based Management' it is the foundation of everything the company delivers.

For further information visit www.ardentia.co.uk.

About AFA

  • As a special offer AFA is available for 33% off until 21 March, 2011.
  • AFA is a hosted subscription service accessible via Internet Explorer, so it can be deployed instantly.
  • It has an intuitive, browser-based GUI that visualises and geographically maps referral volumes, and enables clinicians to drill down into referral data by speciality, HRG, location, patient age and gender, and period. This helps in understanding referral flows and case mixes in detail, and supports analysis of how these patterns change over time.

1. Chief Executive Newcastle under Lyme Primary Care Trust from April 2002 to October 2006. He now provides consultancy services for a range of Trusts and GP's and Ardentia is among his clients.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...